Metformin and/or Clomiphene Do Not Adversely Affect Liver or Renal Function in Women with Polycystic Ovary Syndrome

CONTEXT: Nonalcoholic fatty liver disease is common to insulin-resistant states such as polycystic ovary syndrome (PCOS). Metformin (MET) is often used to treat PCOS but information is limited as to its effects on liver function. OBJECTIVE: We sought to determine the effects of MET on serum hepatic...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Aubuchon, Mira, Kunselman, Allen R., Schlaff, William D., Diamond, Michael P., Coutifaris, Christos, Carson, Sandra A., Steinkampf, Michael P., Carr, Bruce R., McGovern, Peter G., Cataldo, Nicholas A., Gosman, Gabriella G., Nestler, John E., Myers, Evan R., Legro, Richard S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Endocrine Society 2011
Soggetti:
JCEM Online: Brief Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3200244/
https://ncbi.nlm.nih.gov/pubmed/21832111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2011-1093
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi